-
1
KinetiSol technology focuses on solubility challenges in drug formulation.
-
2
It targets 'brick dust molecules' that are poorly soluble.
-
3
The process uses excipients as solvents without organic solvents.
-
4
It generates a malleable mass through mechanical energy.
-
5
Final products are dense, free-flowing particles.
-
6
Developed from insights in plastics mixing technology.
-
7
Designed for efficiency in pharmaceutical manufacturing.
Original Source(s)
Solving the Problem of Insolubility: Part II
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
February 24, 2026
-
6 min
Related Content
Sticky Situation; Sticky Solution
Image of the Month: engineered algae aggregating microplastics
February 20, 2026
-
1 min
UK: More than a Million Over 40s Living with Glaucoma
New modeling data estimate higher glaucoma prevalence in the UK, with cases expected to increase over the coming decades
February 20, 2026
-
3 min
How Lead Exposure Changed Over a Century
Hair-based mass spectrometry links declining lead exposure to environmental regulation
February 17, 2026
-
2 min
